MarketPulse

hedge fund strategy

3 articles
The Motley FoolThe Motley Fool··Cory Renauer

CIBRA Capital Doubles Down on Amicus Therapeutics Merger Arbitrage Play

CIBRA Capital increases Amicus Therapeutics stake to 11.78% of AUM, betting on BioMarin's $14.50 acquisition for $0.20 per share profit.
FOLDBMRNacquisition13F filing
The Motley FoolThe Motley Fool··Trevor Jennewine

Billionaires Dump Nvidia While Wall Street Backs AI Chip Leader

Billionaire hedge fund managers sell Nvidia, buy Micron, bucking Wall Street consensus favoring Nvidia's sustainable AI growth over Micron's temporary supply-driven earnings boom.
NVDAMUGOOGGOOGLvaluationearnings growth
BenzingaBenzinga··Erica Kollmann

Druckenmiller Shifts Portfolio Away From Tech Toward Brazil and Value Plays

Druckenmiller reduces tech holdings, adds $113M Brazil position via EWZ ETF. Shifts portfolio toward value plays and financial services from mega-cap growth.
METASNDKGOOGGOOGLRSP+4emerging marketsvalue investing